Show simple item record

dc.creatorFuchs, Victor R.en
dc.creatorGarber, Alan M.en
dc.date.accessioned2015-05-05T18:39:15Zen
dc.date.available2015-05-05T18:39:15Zen
dc.date.created1990-09-06en
dc.date.issued1990-09-06en
dc.identifier10.1056/NEJM199009063231011en
dc.identifier.bibliographicCitationNew England Journal of Medicine. 1990 Sep 6; 323(10): 673-677.en
dc.identifier.issn0028-4793en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=The+New+Technology+Assessment&title=New+England+Journal+of+Medicine.+&volume=323&issue=10&pages=673-677&date=1990&au=Fuchs,+Victor+R.en
dc.identifier.urihttp://dx.doi.org/10.1056/NEJM199009063231011en
dc.identifier.urihttp://hdl.handle.net/10822/737987en
dc.description.abstractThe authors of this Sounding Board article discuss how the new approach to assessment of biomedical technologies that incorporates considerations of effectiveness, patient preferences, and costs, differs from the old approach to evaluating medical innovation with its emphasis on efficacy and safety. Fuchs and Garber explain what is new about technology assessment, how technology assessment in medicine differs from that in other industries, what makes a good assessment, and the usual stages and timing of an assessment. They also discuss what technology assessment can and cannot do, particularly its inability to provide a simple answer to the question of whether a particular medical intervention is worthwhile. Fuchs and Garber caution physicians against rejecting technology assessment out of hand and payers against relying on assessment to reduce health care costs without taking into account incentives that often promote unnecessary and inefficient health care practices. (KIE abstract)en
dc.formatArticleen
dc.languageenen
dc.sourceBRL:KIE/31566en
dc.subjectBiomedical Technologiesen
dc.subjectCosts and Benefitsen
dc.subjectDecision Makingen
dc.subjectEconomicsen
dc.subjectEvaluationen
dc.subjectGenetic Screeningen
dc.subjectHealthen
dc.subjectHealth Careen
dc.subjectHealth Care Deliveryen
dc.subjectHuman Experimentationen
dc.subjectIncentivesen
dc.subjectIndustryen
dc.subjectInsuranceen
dc.subjectLifeen
dc.subjectMedicineen
dc.subjectMethodsen
dc.subjectPatient Careen
dc.subjectPhysiciansen
dc.subjectQuality of Lifeen
dc.subjectRemunerationen
dc.subjectResource Allocationen
dc.subjectReviewen
dc.subjectSocial Impacten
dc.subjectTechnologyen
dc.subjectTechnology Assessmenten
dc.titleThe New Technology Assessmenten
dc.provenanceDigital citation created by the National Reference Center for Bioethics Literature at Georgetown University for the BIOETHICSLINE database, part of the Kennedy Institute of Ethics' Bioethics Information Retrieval Project funded by the United States National Library of Medicine.en
dc.provenanceDigital citation migrated from OpenText LiveLink Discovery Server database named NBIO hosted by the Bioethics Research Library to the DSpace collection BioethicsLine hosted by Georgetown University.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885